Advertisement

Colorectal Cancer Prevention

  • Ayaaz Ismail
  • Eugene Gerner
  • Peter Lance

Keywords

Familial Adenomatous Polyposis Primary Sclerosing Cholangitis Flexible Sigmoidoscopy Colorectal Neoplasia Advanced Adenoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlquist, D. A., J. E. Skoletsky, et al. (2000). "Colorectal cancer screening by detection of altered human DNA in stool: Feasability of a multitarget assay panel." Gastroenterology 119: 1219–1227.CrossRefPubMedGoogle Scholar
  2. Ahlquist, D.A., H.S. Wieand, et al. (1993). "Accuracy of fecal occult blood screening for colorectal neoplasia." JAMA 269: 1262–1267.CrossRefPubMedGoogle Scholar
  3. Alberts, D.S., M.E. Martínez, et al. (2004). "Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence." Submitted for publication.Google Scholar
  4. Alberts, D.S., M.E. Martínez, et al. (2000). "Lack of effect of a high-fiber cereal Supplement on the recurrence of colorectal adenomas." N Engl J Med 342: 1156–1162.CrossRefPubMedGoogle Scholar
  5. Atkin, W.S., J. Cuzick, et al. (2002). "Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial." Lancet 359: 1291–1300.CrossRefPubMedGoogle Scholar
  6. Atkin, W.S., J. Cuzick, et al. (1993). "Prevention of colorectal cancer by once-only sigmoidoscopy." Lancet 341: 736–740.CrossRefPubMedGoogle Scholar
  7. Baris, D., G. Gridley, et al. (2002). "Acromegaly and cancer risk: a cohort study in Sweden and Denmark." Cancer Causes Control 13(5): 395–400.CrossRefPubMedGoogle Scholar
  8. Baron, J.A., M. Beach, et al. (1999). "Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group." N Engl J Med 340(2): 101–107.CrossRefPubMedGoogle Scholar
  9. Baron, J.A., B.F. Cole, et al. (2003). "A randomized trial of aspirin to prevent colorectal adenomas." N Engl J Med 348: 891–899.CrossRefPubMedGoogle Scholar
  10. Benamouzig, R., J. Deyra, et al. (2003). "Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC triali." Gastroenterology 125(2): 328–336.CrossRefPubMedGoogle Scholar
  11. Bingham, S. and E. Riboli (2004). "Diet and cancer — the European Prospective Investigation into Cancer and Nutrition" Nat Rev Cancer 4(3): 206–215.CrossRefPubMedGoogle Scholar
  12. Bowles, C.J., R. Leicester, et al. (2004). "A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?" Gut 53(2): 277–283.CrossRefPubMedGoogle Scholar
  13. BRFSS (2002). Colorectal Cancer Screening — 2002. Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Behavioral Risk Factor Surveillance System Online Prevalence Data, 1995–2002.Google Scholar
  14. Card, T., R. Hubbard, et al. (2003). "Mortality in inflammatory bowel disease: a population-based cohort study." Gastroenterology 125(6): 1583–1590.CrossRefPubMedGoogle Scholar
  15. Chan, A.T., E.L. Giovannucci, et al. (2004). "A prospective study of aspirin use and the risk for colorectal adenoma." Ann Intern Med 140(3): 157–166.PubMedGoogle Scholar
  16. Chan, T.A., P.J. Morin, et al. (1998). "Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis." Proc Natl Acad Sci USA 95: 681–686.CrossRefPubMedGoogle Scholar
  17. Choi, P.M., F.W. Nugent, et al. (1993). "Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis." Gastroenterology 105(2): 418–424.PubMedGoogle Scholar
  18. Citarda, F., G. Tomaselli, et al. (2001). "Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence." Gut 48(6): 812–815.CrossRefPubMedGoogle Scholar
  19. Clark, L, J. Combs, J.F., et al. (1996). "Effects of selenium supplementation for cancer prevention in patient with carcinomas of the skin." JAMA 276: 1957–1963.CrossRefPubMedGoogle Scholar
  20. Coffield, A.B., M.V. Maciosek, et al. (2001). "Priorities among recommended clinical preventive services." Am J Prev Med 21(1): 1–9.CrossRefGoogle Scholar
  21. Colditz, G.A., C.C. Cannuscio, et al. (1997). "Physical activity and reduced risk of colon cancer: implications for prevention." Cancer Causes Control 8(4): 649–667.CrossRefPubMedGoogle Scholar
  22. Cooper, G.S., Z. Yuan, et al. (1995). "A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans." Cancer 75(3): 775–781.PubMedGoogle Scholar
  23. Cotton, P.B., V.L. Durkalski, et al. (2004). "Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia." JAMA 291(14): 1713–1719.CrossRefPubMedGoogle Scholar
  24. Cruz-Correa, M., L.M. Hylind, et al. (2002). "Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study." Gastroenterology 122(3): 641–645.CrossRefPubMedGoogle Scholar
  25. Cryer, B. (2002). "Gastrointestinal safety of low-dose aspirin." Am J Manag Care 8(22 Suppl): S701–708.PubMedGoogle Scholar
  26. Duffield-Lillico, A.J., M.E. Reid, et al. (2002). "Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial." Cancer Epidemiol Biomarkers Prev 11(7): 630–639.PubMedGoogle Scholar
  27. Fitzgerald, G.A. (2004). "Coxibs and cardiovascular disease." N Engl J Med 351(17): 1709–1711.CrossRefPubMedGoogle Scholar
  28. Frazier, A.L., G.A. Colditz, et al. (2000). "Cost-effectiveness of screening for colorectal cancer in the general population." JAMA 284: 1954–1961.CrossRefPubMedGoogle Scholar
  29. Friedenreich, C.M. (2001). "Physical activity and cancer prevention: from observational to intervention research." Cancer Epidemiol Biomarkers Prev 10: 287–301.PubMedGoogle Scholar
  30. Fuchs, C.S., W.C. Willett, et al. (2002). "The influence of folate and multivitamin use on the familial risk of colon cancer in women." Cancer Epidemiol Biomarkers Prev 11: 227–234.PubMedGoogle Scholar
  31. Gatto, N.M., H. Frucht, et al. (2003). "Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study." J Natl Cancer Inst 95(3): 230–236.PubMedGoogle Scholar
  32. Giardiello, F.M., V.W. Yang, et al. (2002). "Primary chemoprevention of familial adenomatous polyposis with sulindac." N Engl J Med 346: 1054–1059.CrossRefPubMedGoogle Scholar
  33. Giardiello, F.M., V.W. Yang, et al. (2002). "Primary chemoprevention of familial adenomatous polyposis with sulindac." N Engl J Med 346(14): 1054–1059.CrossRefPubMedGoogle Scholar
  34. Giovannucci, E., E.B. Rimm, et al. (1995). "Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men." J Natl Cancer Inst 87(4): 265–273.PubMedGoogle Scholar
  35. Giovannucci, E.L., M.J. Stampfer, et al. (1998). "Multivitamin use, folate, and colon cancer in women in nurses' health study." Ann Intern Med 129: 517–524.PubMedGoogle Scholar
  36. Gonzalez-Juanatey, C., M.A. Gonzalez-Gay, et al. (2003). "Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature." Can J Cardiol 19(10): 1139–1145.PubMedGoogle Scholar
  37. Grady, W.M. (2003). "Genetic testing for high-risk colon cancer patients." Gastroenterology 124(6): 1574–1594.CrossRefPubMedGoogle Scholar
  38. Grau, M.V., J.A. Baron, et al. (2003). "Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial." J Natl Cancer Inst 95(23): 1765–1771.PubMedGoogle Scholar
  39. Hahn, W.C. and R.A. Weinberg (2002). "Rules for making human tumor cells." N Engl J Med 347: 1593–1603.CrossRefPubMedGoogle Scholar
  40. Hanahan, D. and R.A. Weinberg (2000). "The hallmarks of cancer." Cell 100(1): 57–70.CrossRefPubMedGoogle Scholar
  41. He, J., R K. Whelton, et al. (1998). "Aspirin and risk of hemorrhagic stroke." JAMA 280:1930–1935.CrossRefPubMedGoogle Scholar
  42. He, T.-C., T.A. Chan, et al. (1999). "PPAR° is an APC-regulated target of nonsteroidal anti-inflammatory drugs." N Engl J Med 99: 335–345.Google Scholar
  43. Imperiale, T.F., D.R. Wagner, et al. (2000). "Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings." N Engl J Med 343: 169–174.CrossRefPubMedGoogle Scholar
  44. Ionov, Y., M.A. Peinado, et al. (1993). "Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis." Nature 363(6429): 558–561.CrossRefPubMedGoogle Scholar
  45. Jayaram, H., J. Satsangi, et al. (2001). "Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?" Gut 48(3): 430–434.CrossRefPubMedGoogle Scholar
  46. Jemal, A., R.C. Tiwari, et al. (2004). "Cancer statistics, 2004." CA Cancer J Clin 54(1): 8–29.PubMedGoogle Scholar
  47. Jess, T., K.V. Winther, et al. (2004). "Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark." Aliment Pharmacol Ther 19(3): 287–293.CrossRefPubMedGoogle Scholar
  48. Kim, Y.I. (2000). "AGA technical review: impact of dietary fiber on colon cancer occurrence." Gastroenterology 118(6): 1235–1257.PubMedGoogle Scholar
  49. Kinzler, K.W. and B. Vogelstein (1996). "Lessons from hereditary colorectal cancer." Cell 87: 159–170.CrossRefPubMedGoogle Scholar
  50. Lamprecht, S.A. and M. Lipkin (2003). "Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms." Nat Rev Cancer 3(8): 601–614.CrossRefPubMedGoogle Scholar
  51. Lengauer, C., K.W. Kinzler, et al. (1998). "Genetic instabilities in human cancers." Nature 396: 643–649.CrossRefPubMedGoogle Scholar
  52. LeRoith, D., R. Baserga, et al. (1995). "Insulin-like growth factors and cancer." Ann Intern Med 122(1): 54–59.PubMedGoogle Scholar
  53. Leslie, A., F.A. Carey, et al. (2002). "The colorectal adenoma-carcinoma sequence." Br J Surg 89: 845–860.CrossRefPubMedGoogle Scholar
  54. Lieberman, D.A. and D.G. Weiss (2001). "One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon." N Engl J Med 345: 555–560.CrossRefPubMedGoogle Scholar
  55. Lieberman, D.A., D.G. Weiss, et al. (2000). "Use of colonoscopy to screen asymptomatic adults for colorectal cancer." N Engl J Med 343: 162–168.CrossRefPubMedGoogle Scholar
  56. Lindor, N.M. (2004). "Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes." Clin Gastroenterol Hepatol 2(5): 366–375.CrossRefPubMedGoogle Scholar
  57. Ma, J., E. Giovannucci, et al. (2004). "A prospective study of plasma C-peptide and colorectal cancer risk in men." J Natl Cancer Inst 96(7): 546–553.PubMedGoogle Scholar
  58. Ma, J., M. N. Pollak, et al. (1999). "Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3." J Natl Cancer Inst 91(7): 620–625.CrossRefPubMedGoogle Scholar
  59. Mandel, J.S., J.H. Bond, et al. (1993). "Reducing mortality from colorectal cancer by screening for fecal occult blood." N Engl J Med 328: 1365–1371.CrossRefPubMedGoogle Scholar
  60. Mandel, J.S., T.R. Church, et al. (2000). "The effect of fecal occult-blood screening on the incidence of colorectal cancer." N Engl J Med 343(22): 1603–1607.CrossRefPubMedGoogle Scholar
  61. Mandel, J.S., T.R. Church, et al. (1999). "Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood." J Natl Cancer Inst 91: 434–437.CrossRefPubMedGoogle Scholar
  62. Martinez, M.E., T.G. O'Brien, et al. (2003). "Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene." Proc Natl Acad Sci USA 100(13): 7859–7864.CrossRefPubMedGoogle Scholar
  63. Mason, J.B. (2002). "Nutritional chemoprevention of colon cancer." Semin Gastrointest Dis 13(3): 143–153.PubMedGoogle Scholar
  64. Munkholm, P. (2003). "Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease." Aliment Pharmacol Ther 18Suppl 2: 1–5.CrossRefGoogle Scholar
  65. Nelson, E.B., K.R. McQuaid, et al. (2002). "Procedural success and complications of largescale screening colonoscopy." Gastrointest Endosc 55: 307–314.CrossRefPubMedGoogle Scholar
  66. Newcomb, P.A., R.G. Norfleet, et al. (1992). "Screening sigmoidoscopy and colorectal cancer mortality." J Natl Cancer Inst 84(20): 1572–1575.PubMedGoogle Scholar
  67. Niv, Y., M. Lev-El, et al. (2002). "Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers." Gut 50(1): 33–37.CrossRefPubMedGoogle Scholar
  68. Palmqvist, R., G. Hallmans, et al. (2002). "Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden." Gut 50(5): 642–646.CrossRefPubMedGoogle Scholar
  69. Pardi, D.S., E.V. Loftus, Jr., et al. (2003). "Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis." Gastroenterology 124: 889–893.CrossRefPubMedGoogle Scholar
  70. Peters, U., R. Sinha, et al. (2003). "Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme." Lancet 361(9368): 1491–1495.CrossRefPubMedGoogle Scholar
  71. Pickhardt, P.J., J.R. Choi, et al. (2003). "Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults." N Engl J Med 349(23): 2191–2200.CrossRefPubMedGoogle Scholar
  72. Pignone, M., M. Rich, et al. (2002). "Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force." Ann Intern Med 137(2): 132–141.PubMedGoogle Scholar
  73. Potter, J.D. (1999). "Colorectal cancer: molecules and populations." J Natl Cancer Inst 91(11): 916–932.CrossRefPubMedGoogle Scholar
  74. Rahme, E., A.N. Barkun, et al. (2003). "The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence." Gastroenterology 125(2): 404–412.CrossRefPubMedGoogle Scholar
  75. Rajagopalan, H., M.A. Nowak, et al. (2003). "The significance of unstable chromosomes in colorectal cancer." Nat Rev Cancer 3(9): 695–701.CrossRefPubMedGoogle Scholar
  76. Rex, D.K. (2004). "American college of gastroenterology action plan for colorectal cancer prevention." Am J Gastroenterol 99(4): 574–577.CrossRefPubMedGoogle Scholar
  77. Rex, D.K., C.S. Cutler, et al. (1997). "Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies." Gastroenterology 112: 24–28.PubMedGoogle Scholar
  78. Rex, D.K., G.A. Lehman, et al. (1994). "The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination." Gastroenterology 106: 593–595.PubMedGoogle Scholar
  79. Rutter, M., B. Saunders, et al. (2004). "Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis." Gastroenterology 126(2): 451–459.CrossRefPubMedGoogle Scholar
  80. Sandler, R.S., S. Halabi, et al. (2003). "A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer." N Engl J Med 348: 883–890.CrossRefPubMedGoogle Scholar
  81. Schatzkin, A., E. Lanza, et al. (2000). "Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas." N Engl J Med 342: 1149–1155.CrossRefPubMedGoogle Scholar
  82. Schoen, R. E., P. F. Pinsky, et al. (2003). "Results of repeat sigmoidoscopy 3 years after a negative examination." JAMA 290(1): 41–48.CrossRefPubMedGoogle Scholar
  83. Schoenfeld, R., S. Lipscomb, et al. (1999). "Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: A randomized trial." Gastroenterology 117: 312–318.CrossRefPubMedGoogle Scholar
  84. Selby, J.V., G. D. Friedman, et al. (1992). "A case-control study of screening sigmoidoscopy and mortality from colorectal cancer." N Engl J Med 326: 653–657.PubMedGoogle Scholar
  85. Serfaty, L., A. De Leusse, et al. (2003). "Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study." Hepatology 38(1): 203–209.CrossRefPubMedGoogle Scholar
  86. Slattery, M. L., S. Edwards, et al. (2003). "Physical activity and colorectal cancer." Am J Epidemiol 158(3): 214–224.CrossRefPubMedGoogle Scholar
  87. Smith, R.A., V. Cokkinides, et al. (2004). "American Cancer Society guidelines for the early detection of cancer, 2004." CA Cancer J Clin 54(1): 41–52.PubMedGoogle Scholar
  88. Spirio, L.N., W. Samowitz, et al. (1998). "Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps." Nat Genet 20: 385–388.CrossRefPubMedGoogle Scholar
  89. Steinbach, G., P.M. Lynch, et al. (2000). "The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis." N Engl J Med 342: 1946–1952.CrossRefPubMedGoogle Scholar
  90. Tagore, K.S., M.J. Lawson, et al. (2003). "Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia." Clin Colorectal Cancer 3(1): 47–53.PubMedGoogle Scholar
  91. Thun, M.J., S.J. Henley, et al. (2002). "Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues." J Natl Cancer Inst 94: 252–266.PubMedGoogle Scholar
  92. Topol, E.J. (2004). "Failing the public health-rofecoxib, Merck, and the FDA." N Engl J Med 351(17): 1707–1709.CrossRefPubMedGoogle Scholar
  93. Toyota, M., C. Ho, et al. (1999). "Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification." Cancer Res 59(10): 2307–2312.PubMedGoogle Scholar
  94. Traverso, G., A.P. Shuber, et al. (2001). "Detection of APC mutations in fecal DNA from patients with colorectal tumors." N Engl J Med 346: 311–320.CrossRefGoogle Scholar
  95. Tung, B.Y., M.J. Emond, et al. (2001). "Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis." Ann Intern Med 134: 89–95.PubMedGoogle Scholar
  96. Vogelstein, B., E. R. Fearon, et al. (1988). "Genetic alterations during colorectal-tumor development." N Engl J Med 319(9): 525–532.PubMedGoogle Scholar
  97. Ward, E., A. Jemal, et al. (2004). "Cancer disparities by race/ethnicity and socioeconomic status." CA Cancer J Clin 54(2): 78–93.PubMedGoogle Scholar
  98. Whynes, D.K., E.J. Frew, et al. (2003). "Colorectal cancer, screening and survival: the influence of socio-economic deprivation." Public Health 117(6): 389–395.CrossRefPubMedGoogle Scholar
  99. Winawer, S.J., R.H. Fletcher, et al. (1997). "Colorectal cancer screening: Clinical guidelines and rationale." Gastroenterology 112: 594–642.CrossRefPubMedGoogle Scholar
  100. Winawer, S.J., R.H. Fletcher, et al. (2003). "Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence." Gastroenterology 124: 544–560.CrossRefPubMedGoogle Scholar
  101. Winawer, S.J., E.T. Stewart, et al. (2000). "A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy." N Engl J Med 342: 1766–1772.CrossRefPubMedGoogle Scholar
  102. Winawer, S.J., A.G. Zauber, et al. (1993). "Prevention of colorectal cancer by colonoscopic polypectomy." N Engl J Med 329: 1977–1981.CrossRefPubMedGoogle Scholar
  103. Winther, K.V., T. Jess, et al. (2003). "Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County." Gastroenterology 125(6): 1576–1582.CrossRefPubMedGoogle Scholar
  104. Woodhouse, C.R. (2002). "Guidelines for monitoring of patients with ureterosigmoidostomy." Gut 51(Suppl 5): VI5–16.Google Scholar
  105. Young, G.P., D.J. St John, et al. (2003). "Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin." J Med Screen 10(3): 123–128.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2005

Authors and Affiliations

  • Ayaaz Ismail
    • 1
  • Eugene Gerner
    • 1
  • Peter Lance
    • 1
  1. 1.College of MedicineUniversity of ArizonaTucson

Personalised recommendations